You are here

  • Home
  • Archive
  • Volume 12, Issue 6
  • HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype

Article metrics

Article menu
Immunotherapy biomarkers
Original research
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype

 

Online download statistics by month:

Online download statistics by month: June 2024 to August 2025

AbstractFullPdf
Jun 2024515521216
Jul 2024190191106
Aug 202411911881
Sep 202412012184
Oct 202412112256
Nov 202412612770
Dec 202413513664
Jan 202510010165
Feb 202523223245
Mar 202511411454
Apr 202513913979
May 202511311473
Jun 2025414128
Jul 2025110
Aug 2025110
Total206720791021